Tnuva

Pluri CEO Issues Letter to Shareholders Announcing New Tech Collaboration, Cost Reduction in line with New Strategy and Financial Updates

Retrieved on: 
Thursday, September 29, 2022
Tnuva, Confidentiality, Food industry, PLUR, American, Meat, TASE, Growth, Biotechnology, Plural, Industry, API, Technology, Cell, Nasdaq, Liver, Secure, Food security, GLOBE, Animal, Awareness, GMP, Seafood, Regenerative medicine, Fine chemical, Pharmaceutical industry, Renewable energy, Agriculture

Earlier this year, Pluri signed a landmark collaboration agreement with Tnuva Group, Israels largest food producer to establish a cultivated food platform based on Pluris technology.

Key Points: 
  • Earlier this year, Pluri signed a landmark collaboration agreement with Tnuva Group, Israels largest food producer to establish a cultivated food platform based on Pluris technology.
  • Today, I am pleased to announce an additional technology collaboration, this time in the biologics industry.
  • We have entered a collaboration agreement with one of the worlds leading manufacturers of specialty biologic APIs for liver and gastroenterological diseases.
  • Over the past few months, we have made significant cost reductions to align our business with our new strategy.

Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New Partnership

Retrieved on: 
Monday, March 28, 2022
TASE, Company, Migros, Private Securities Litigation Reform Act, Therapy, Regenerative medicine, LinkedIn, Method, Tempo, Sale, Marketing, Wind, Legislation, Pressure, CEO, Bell, Israel Innovation Authority, U.S. Securities and Exchange Commission, CVC, Food industry, Nasdaq MarketSite, Fresh Start, Technology, Knowledge, Inflammation, Nasdaq, Finistère, GLOBE, Science, Tnuva, R, Closing Bell, Engineering, Security (finance), Online gambling, Fine chemical, Pharmaceutical industry, Pluristem Therapeutics

HAIFA, Israel, March 28, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI) (“Pluristem”), a leading biotechnology company, and Tnuva Group (“Tnuva Group” or “Tnuva”), Israel’s largest food producer, today announced that Pluristem’s CEO and President Yaky Yanay and Tnuva Group’s Chairman, Haim Gavrieli, will ring the Closing Bell at Nasdaq MarketSite in Times Square, New York. The ceremony, in honor of the companies’ launch of an innovative collaboration to develop, manufacture and commercialize cultured cell-based products for the food industry, will take place on Monday, March 28, 2022 at 3:45 pm ET.

Key Points: 
  • We are honored to celebrate this important collaboration between Pluristem and Tnuva at Nasdaq, said Yaky Yanay, CEO and President of Pluristem.
  • Over the years, Pluristem has developed one of the most advanced cell-based technology platforms, offering mass-scale, cost-effective, consistent cell production.
  • Haim Gavrieli, Chairman of Tnuva Group: I am excited to note the groundbreaking collaboration between Pluristem and Tnuva Group.
  • Pluristem (Nasdaq: PSTI) is pushing the boundaries of science and engineering to produce cell-based products for various industries on a global scale.

Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint Venture

Retrieved on: 
Tuesday, March 8, 2022
Private Securities Litigation Reform Act, World Bank Group, Leadership, Regenerative medicine, Industry, Science, Security (finance), U.S. Securities and Exchange Commission, Israel Innovation Authority, Fresh Start, Knowledge, International Finance Corporation, Tnuva, Therapy, Growth, Method, Map, Migros, Legislation, Sale, Head, Infinity Group, Food, Inflammation, Marketing, TASE, Science and technology in Asia, Agriculture, CVC, Placenta, Finistère, Intellectual property, Engineering, Technology, R, Pressure, Nasdaq, Rosenthal, Meat, GLOBE, Tempo, Renewable energy, Fine chemical, Pluristem Therapeutics

Mr. Rosenthal also served as Executive Chairman of Fresh Start, a leading global food tech incubator backed by the Israel Innovation Authority, as well as top strategic and financial players.

Key Points: 
  • Mr. Rosenthal also served as Executive Chairman of Fresh Start, a leading global food tech incubator backed by the Israel Innovation Authority, as well as top strategic and financial players.
  • Food tech is on the rise and I am excited to be joining this new venture as we aim to transform the food system, especially the way we produce meat, said Mr. Rosenthal.
  • We believe that Eyal will position us as a leader in the global food tech industry, said Yaky Yanay, Chief Executive Officer and President of Pluristem.
  • Eyal is a food tech veteran and has an impressive track record as a trailblazer in the industry, said Eyal Malis, Chief Executive Officer of Tnuva Group.

Pluristem CEO Issues Shareholder Update

Retrieved on: 
Wednesday, March 2, 2022
Private Securities Litigation Reform Act, Regenerative medicine, Science, Security (finance), U.S. Securities and Exchange Commission, Knowledge, Tnuva, Therapy, Method, CRISPR, Calendar, Food, Inflammation, TASE, Cell, Fruit, Placenta, Engineering, Technology, Partnership, Pressure, Nasdaq, Legislation, Meat, GLOBE, Courage, Fine chemical, Pluristem Therapeutics

HAIFA, Israel, March 02, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company, today issued an update to its shareholders from its Chief Executive Officer and President, Yaky Yanay.

Key Points: 
  • HAIFA, Israel, March 02, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company, today issued an update to its shareholders from its Chief Executive Officer and President, Yaky Yanay.
  • As I look ahead, I am more confident about the direction of Pluristem than ever before.
  • Pluristem is pushing the boundaries of science and engineering to create cell-based products for commercial use.
  • For a more detailed description of the risks and uncertainties affecting Pluristem, reference is made to Pluristem's reports filed from time to time with the Securities and Exchange Commission.

Pluristem Announce the Closing of its Collaboration with Tnuva Group to Establish Cultured Food Platform

Retrieved on: 
Thursday, February 24, 2022
GLOBE, Dairy, Partnership, Israel Innovation Authority, Method, Wind, Intellectual property, Inflammation, Security (finance), Regenerative medicine, Food industry, Private Securities Litigation Reform Act, TASE, U.S. Securities and Exchange Commission, Finistère, Egg, Meat, Science, Pressure, Nasdaq, Engineering, Technology, Placenta, Knowledge, Legislation, CEO, Fine chemical, Life insurance, Pharmaceutical industry, Food delivery, NewCo, Pluristem Therapeutics, Tnuva

The collaboration is a major step forward to bringing sustainable cultured food to everyday consumers globally.

Key Points: 
  • The collaboration is a major step forward to bringing sustainable cultured food to everyday consumers globally.
  • Tnuva Group is the largest food producer in Israel, as well as the Israeli leader in the field of alternative dairy and protein products.
  • Tnuva holds Israels leading and most loved food brands in Israel, with approximately 4 million of Tnuva Groups products sold daily.
  • The collaboration with Tnuva supports Pluristems strategy to establish partnerships leveraging Pluristems cell-based technology platform.

Biotechnology Company Pluristem, and Israel’s Largest Food Producer Tnuva, Launch Landmark Collaboration to Establish Cultured Food Platform

Retrieved on: 
Monday, January 10, 2022
Knowledge, TASE, Party, Dairy, Intention, Migros, Israel Innovation Authority, Meat, Legislation, Concept, EST, Industry, Engineering, Security (finance), Method, Marketing, U.S. Securities and Exchange Commission, Food industry, Science, Regenerative medicine, Finistère, Research, Therapy, R, Pressure, CEO, IST, Company, Ischemia, Private Securities Litigation Reform Act, Nasdaq, Technology, Egg, Placenta, Intellectual property, Wind, GLOBE, Proof of concept, Food, Inflammation, Fine chemical, 3D printing, Risk management, Tnuva, Pluristem Therapeutics, NewCo

As part of the collaboration, the Parties may expand the collaboration to include cultured dairy and cultured fish products by establishing separate, new ventures.

Key Points: 
  • As part of the collaboration, the Parties may expand the collaboration to include cultured dairy and cultured fish products by establishing separate, new ventures.
  • Haim Gavrieli, Chairman of Tnuva Group: Our collaboration with Pluristem is part of the execution of Tnuva Groups strategy and vision.
  • We expect the collaboration between the companies to revolutionize the cultured food industry and develop the next generation of alternative proteins.
  • The collaboration with Tnuva supports Pluristem's strategy to establish partnerships that leverage its cell-based technology platform.

Finistere, OurCrowd, Tnuva, and Tempo Awarded Government Tender to Operate Israel’s FoodTech Incubator in the North

Retrieved on: 
Tuesday, June 11, 2019
Technology, Other Technology, Natural Resources, Agriculture, Other Natural Resources, Retail, Food, Beverage, Hague School, Jozef Israëls, Tnuva, Kiryat Shmona, Artists, Painters, Visual arts

This is an important milestone in establishing a full FoodTech ecosystem in Israels north.

Key Points: 
  • This is an important milestone in establishing a full FoodTech ecosystem in Israels north.
  • Our group represents the best of Israels food industry and leading venture capital groups from Israel and around the world.
  • Tnuva CEO Eyal Malis said, The real winner in this tender is Israels north and Kiryat Shemona, where we are going to fund over 40 new FoodTech companies that will create hundreds of new quality jobs.
  • Together with our partners, we are going to invest significant resources and knowledge, making this new incubator a massive success.

Finistere Ventures, OurCrowd, Tnuva, and Tempo Beverages Announce Partnership to Invest $100 Million in Israeli FoodTech and AgTech Innovation

Retrieved on: 
Tuesday, May 28, 2019
Other Consumer, Technology, Supply chain management, Other Technology, Manufacturing, Other Manufacturing, Retail, Food, Beverage, Consumer, OurCrowd, Tnuva, Innovation, Articles, Economy

The partnership was created following the Israeli governments establishment of an innovation incubator in Northern Israel focused on FoodTech.

Key Points: 
  • The partnership was created following the Israeli governments establishment of an innovation incubator in Northern Israel focused on FoodTech.
  • Finistere Ventures, OurCrowd, Tnuva and Tempo Beverages will be bidding to operate the incubator being built as part of Kiryat Shemonas planned innovation center, to intensify their investment in the Israeli FoodTech community.
  • Co-Founder and Partner at Finistere Ventures Arama Kukutai said, Israel has become a top innovation hub in the FoodTech and AgTech arena.
  • OurCrowd CEO Jon Medved said, FoodTech is now one of the hottest dishes on the Israeli innovation menu.